Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon bought 10 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was purchased at an average cost of GBX 2,342 per share, for a total transaction of £234.20.
Liam Condon also recently made the following trade(s):
- On Tuesday, January 13th, Liam Condon bought 10 shares of Johnson Matthey stock. The shares were purchased at an average price of GBX 2,321 per share, with a total value of £232.10.
- On Wednesday, December 10th, Liam Condon bought 14 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 2,013 per share, with a total value of £281.82.
Johnson Matthey Trading Up 0.2%
LON JMAT opened at GBX 2,345 on Friday. The firm has a market capitalization of £3.93 billion, a price-to-earnings ratio of -35.58, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. Johnson Matthey PLC has a one year low of GBX 1,131 and a one year high of GBX 2,434. The company’s 50 day moving average price is GBX 2,242.69 and its 200 day moving average price is GBX 2,070.92.
Analyst Upgrades and Downgrades
A number of research analysts have commented on JMAT shares. Panmure Gordon restated a “buy” rating and set a GBX 2,370 price objective on shares of Johnson Matthey in a research note on Monday, November 24th. Deutsche Bank Aktiengesellschaft increased their target price on Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the company a “buy” rating in a research note on Wednesday, January 21st. Citigroup boosted their price target on Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the stock a “neutral” rating in a research report on Tuesday, October 21st. Finally, Berenberg Bank decreased their price target on Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating for the company in a report on Tuesday, November 25th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,268.
View Our Latest Stock Analysis on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Articles
- Five stocks we like better than Johnson Matthey
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
